Viewing Study NCT02414269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2026-02-22 @ 7:25 AM
Study NCT ID: NCT02414269
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2015-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Pleural Disease View
None Mesothelioma View
None Metastases View
None Lung Cancer View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None modified T cells View
None cyclophosphamide View
None CAR T cells View
None 15-007 View
None CAR View
None immunotherapy View